Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radoslav Mladenov

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Crohn'S & Colitis|February 25, 2021
Fucosylation and Sialylation of Fc-Fragment of anti-Tumour Necrosis Factor Alpha Antibodies do not Influence Their Immunogenicity in Monocyte-Derived Dendritic CellsMarcin Wawrzyniak, Yasser Morsy, Radoslav Mladenov, et al.
Cancer Immunology, Immunotherapy : CII|October 17, 2015
Novel angiogenin mutants with increased cytotoxicity enhance the depletion of pro-inflammatory macrophages and leukemia cells ex vivoChristian Cremer, Hanna Braun, Radoslav Mladenov, et al.
British Journal of Haematology|October 20, 2017
Elimination of different leukaemia subtypes using novel CD89-specific human cytolytic fusion proteinsGerrit Gresch, Lea Schenke, Radoslav Mladenov, et al.
Molecular Cancer Therapeutics|July 2, 2014
EpCAM-selective elimination of carcinoma cells by a novel MAP-based cytolytic fusion proteinDmitrij Hristodorov, Manal Amoury, Radoslav Mladenov, et al.
Cancer Letters|January 26, 2016
Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor modelManal Amoury, Katharina Kolberg, Anh-Tuan Pham, et al.
Oncotarget|August 27, 2016
CD64-directed microtubule associated protein tau kills leukemic blasts ex vivoRadoslav Mladenov, Dmitrij Hristodorov, Christian Cremer, et al.
International Journal of Cancer|June 5, 2015
The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemiaRadoslav Mladenov, Dmitrij Hristodorov, Christian Cremer, et al.
International Journal of Cancer|April 3, 2016
A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion proteinManal Amoury, Radoslav Mladenov, Thomas Nachreiner, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 9, 2017
Fine Tuning Antibody Conjugation Methods using SNAP-tag TechnologyKarinna Chouman, Mira Woitok, Radoslav Mladenov, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Crohn'S & Colitis|February 25, 2021
Fucosylation and Sialylation of Fc-Fragment of anti-Tumour Necrosis Factor Alpha Antibodies do not Influence Their Immunogenicity in Monocyte-Derived Dendritic CellsMarcin Wawrzyniak, Yasser Morsy, Radoslav Mladenov, et al.
Cancer Immunology, Immunotherapy : CII|October 17, 2015
Novel angiogenin mutants with increased cytotoxicity enhance the depletion of pro-inflammatory macrophages and leukemia cells ex vivoChristian Cremer, Hanna Braun, Radoslav Mladenov, et al.
British Journal of Haematology|October 20, 2017
Elimination of different leukaemia subtypes using novel CD89-specific human cytolytic fusion proteinsGerrit Gresch, Lea Schenke, Radoslav Mladenov, et al.
Molecular Cancer Therapeutics|July 2, 2014
EpCAM-selective elimination of carcinoma cells by a novel MAP-based cytolytic fusion proteinDmitrij Hristodorov, Manal Amoury, Radoslav Mladenov, et al.
Cancer Letters|January 26, 2016
Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor modelManal Amoury, Katharina Kolberg, Anh-Tuan Pham, et al.
Oncotarget|August 27, 2016
CD64-directed microtubule associated protein tau kills leukemic blasts ex vivoRadoslav Mladenov, Dmitrij Hristodorov, Christian Cremer, et al.
International Journal of Cancer|June 5, 2015
The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemiaRadoslav Mladenov, Dmitrij Hristodorov, Christian Cremer, et al.
International Journal of Cancer|April 3, 2016
A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion proteinManal Amoury, Radoslav Mladenov, Thomas Nachreiner, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 9, 2017
Fine Tuning Antibody Conjugation Methods using SNAP-tag TechnologyKarinna Chouman, Mira Woitok, Radoslav Mladenov, et al.
Pageof 2